Cancer Family
Mesenchymal Cell Neoplasm
CI-CAN-00000027Explore in graph →
Non-malignant413 active trials10 approved drugs208 evidence items
- NCIt
- C7059
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000027Explore in graph →
Clinical trials
1,848 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00359333 | Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST(STS) | completed | Phase 2 | 58 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00792766 | Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) | completed | Phase 1 / Phase 2 | 20 | Children's Hospital Medical Center, CincinnatiOTHER |
| 1 |
| Sep 18, 2013 |
| clinicaltrials |
| NCT00030680 | Radiation Therapy in Treating Patients With Aggressive Fibromatoses | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 27, 2013 | clinicaltrials |
| NCT00002595 | Toremifene in Treating Patients With Desmoid Tumors | completed | Phase 2 | 72 | Advocate Lutheran General HospitalOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00570635 | A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib | completed | Phase 2 | 16 | ExelixisINDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00107432 | Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00087074 | CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01261429 | Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | completed | Phase 2 | 50 | Centre Leon BerardOTHER | 5 | Apr 16, 2013 | clinicaltrials |
| NCT00889057 | Sorafenib in Relapsed High Grade Osteosarcoma | completed | Phase 2 | 35 | Italian Sarcoma GroupNETWORK | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00084630 | Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00025246 | Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00005862 | SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00039182 | Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT01452659 | Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids | completed | Phase 2 | 216 | TakedaINDUSTRY | 1 | Jan 21, 2013 | clinicaltrials |
| NCT00025207 | Gefitinib in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00025363 | Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | completed | Phase 2 | 150 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00005597 | S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors | completed | Phase 2 | 25 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00881140 | Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids | completed | Phase 2 | 30 | BioPro Medical LtdINDUSTRY | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00837161 | Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | completed | Phase 1 / Phase 2 | 11 | Philips HealthcareINDUSTRY | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00003939 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 132 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00400569 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | completed | Phase 2 | 48 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00041249 | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00385203 | The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00001566 | A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00237172 | Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) | completed | Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 0 | May 1, 2012 | clinicaltrials |
| NCT00243191 | Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans | completed | Phase 2 | 18 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00931567 | Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing | completed | Phase 2 / Phase 3 | 80 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00112632 | Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | completed | Phase 2 | 40 | Technical University of MunichOTHER | 2 | Mar 8, 2012 | clinicaltrials |
| NCT01091207 | Sorafenib for Imatinib/Sunitinib-failed GIST | completed | Phase 2 | 39 | Samsung Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00500188 | Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST | completed | Phase 2 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00122473 | Imatinib in Dermatofibrosarcoma Protuberans (DFSP) | completed | Phase 1 / Phase 2 | 30 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00940563 | A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors | completed | Phase 2 | 135 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | completed | Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 28, 2011 | clinicaltrials |
| NCT00145639 | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 2 | Jun 10, 2011 | clinicaltrials |
| NCT00572130 | Phase II Study of Intravenous Rexin-G in Osteosarcoma | completed | Phase 2 | 22 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | completed | Phase 2 | 72 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00776074 | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. | completed | Phase 2 | 80 | TakedaINDUSTRY | 0 | Jun 22, 2010 | clinicaltrials |
| NCT00457743 | A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) | completed | Phase 1 / Phase 2 | 36 | PfizerINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00137449 | Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor | completed | Phase 2 | 60 | PfizerINDUSTRY | 3 | Sep 15, 2009 | clinicaltrials |
| NCT00712595 | Mifepristone for Treatment of Uterine Fibroids(Mifemyo) | completed | Phase 2 / Phase 3 | 200 | Mediterranea Medica S. L.OTHER | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00156182 | A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. | completed | Phase 2 | 38 | AbbottINDUSTRY | 0 | Mar 4, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Oct 30, 2013source: clinicaltrials